Segra Expands Plant Tissue Culture Operations into U.S. Hemp Market, Leases Oregon Production Facility

VANCOUVER, British Columbia, June 11, 2019 (GLOBE NEWSWIRE) — Segra International Corp. (“Segra” or the “Company”), an agriculture technology company, is pleased to announce that it will soon begin operations in the United States, providing plant tissue culture services to growers in the emerging federally legal U.S. hemp market. This new operation represents the Company’s premiere entry into the U.S. hemp space, and will be developed concurrently with the Company’s Canadian cannabis strategy.

Following passage of the Agricultural Improvement Act of 2018, hemp was removed from the U.S. Drug Enforcement Agency’s Schedule I drug listing, and is now considered an “agricultural commodity.” Many new U.S. hemp operations are focused on the production of cannabidiol (CBD), a high-value compound found in cannabis plants. However, compliance with U.S. federal law requires that tetrahydrocannabinol (THC) levels in hemp crops remain below 0.3%.

... read more at: